DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Axsome Therapeutics on the offering. Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
You must be a Standard 1 Year member to access this content.
Clifford Chance and Claro & Cia. advised Itau BBA USA Securities, Inc. and Scotia Capital (USA) Inc. on the matter. Milbank and Carey advised Sociedad de...
You must be a Standard 1 Year member to access this content.
